$HQY
HEALTHEQUITY, INC.

2021 Q2 Form 10-Q Financial Statement

#000142833621000025 Filed on June 08, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2
Revenue $184.2M $190.0M
YoY Change -3.06% 118.27%
Cost Of Revenue $81.09M $81.94M
YoY Change -1.04% 179.66%
Gross Profit $103.1M $108.1M
YoY Change -4.59% 87.13%
Gross Profit Margin 55.98% 56.88%
Selling, General & Admin $34.77M $30.45M
YoY Change 14.19% 72.26%
% of Gross Profit 33.72% 28.18%
Research & Development $35.47M $31.08M
YoY Change 14.13% 184.99%
% of Gross Profit 34.4% 28.76%
Depreciation & Amortization $31.77M $27.51M
YoY Change 15.49% 476.3%
% of Gross Profit 30.81% 25.45%
Operating Expenses $98.86M $93.00M
YoY Change 6.3% 209.24%
Operating Profit $4.253M $15.07M
YoY Change -71.78% -45.55%
Interest Expense $6.689M $12.26M
YoY Change -45.45% 19365.08%
% of Operating Profit 157.28% 81.37%
Other Income/Expense, Net -$10.32M -$13.03M
YoY Change -20.79% -155.2%
Pretax Income -$6.066M $2.044M
YoY Change -396.77% -96.01%
Income Tax -$3.500M $218.0K
% Of Pretax Income 10.67%
Net Earnings -$2.615M $1.826M
YoY Change -243.21% -95.63%
Net Earnings / Revenue -1.42% 0.96%
Basic Earnings Per Share -$0.03 $0.03
Diluted Earnings Per Share -$0.03 $0.03
COMMON SHARES
Basic Shares Outstanding 81.75M shares 70.98M shares
Diluted Shares Outstanding 81.75M shares 72.29M shares

Balance Sheet

Concept 2021 Q2 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $736.8M $171.1M
YoY Change 330.61% -48.04%
Cash & Equivalents $736.8M $171.1M
Short-Term Investments
Other Short-Term Assets $53.87M $42.90M
YoY Change 25.57% 420.39%
Inventory
Prepaid Expenses
Receivables $74.47M $69.79M
Other Receivables $0.00 $0.00
Total Short-Term Assets $865.1M $283.8M
YoY Change 204.85% -22.16%
LONG-TERM ASSETS
Property, Plant & Equipment $27.48M $35.82M
YoY Change -23.29% 322.37%
Goodwill $1.364B $1.333B
YoY Change 2.32% 28552.57%
Intangibles $780.8M $777.5M
YoY Change 0.43% 854.7%
Long-Term Investments
YoY Change
Other Assets $38.78M $35.17M
YoY Change 10.26% 63.49%
Total Long-Term Assets $2.297B $2.279B
YoY Change 0.79% 881.93%
TOTAL ASSETS
Total Short-Term Assets $865.1M $283.8M
Total Long-Term Assets $2.297B $2.279B
Total Assets $3.162B $2.562B
YoY Change 23.39% 329.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.636M $7.338M
YoY Change 31.32% 273.63%
Accrued Expenses $73.45M $39.99M
YoY Change 83.68% 338.1%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $62.50M $46.88M
YoY Change 33.33%
Total Short-Term Liabilities $192.3M $134.6M
YoY Change 42.87% 475.78%
LONG-TERM LIABILITIES
Long-Term Debt $909.8M $1.167B
YoY Change -22.05%
Other Long-Term Liabilities $14.81M $3.783M
YoY Change 291.51% 877.52%
Total Long-Term Liabilities $1.121B $1.387B
YoY Change -19.17% 358355.81%
TOTAL LIABILITIES
Total Short-Term Liabilities $192.3M $134.6M
Total Long-Term Liabilities $1.121B $1.387B
Total Liabilities $1.314B $1.522B
YoY Change -13.68% 2159.92%
SHAREHOLDERS EQUITY
Retained Earnings $217.7M $213.3M
YoY Change 2.06% -0.16%
Common Stock $8.000K $7.000K
YoY Change 14.29% 16.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.848B $1.041B
YoY Change
Total Liabilities & Shareholders Equity $3.162B $2.562B
YoY Change 23.39% 329.49%

Cashflow Statement

Concept 2021 Q2 2020 Q2
OPERATING ACTIVITIES
Net Income -$2.615M $1.826M
YoY Change -243.21% -95.63%
Depreciation, Depletion And Amortization $31.77M $27.51M
YoY Change 15.49% 476.3%
Cash From Operating Activities $30.92M $15.03M
YoY Change 105.76% -40.69%
INVESTING ACTIVITIES
Capital Expenditures $2.490M $7.511M
YoY Change -66.85% 567.05%
Acquisitions $49.53M $0.00
YoY Change
Other Investing Activities -$49.53M $0.00
YoY Change -100.0%
Cash From Investing Activities -$67.80M -$25.29M
YoY Change 168.05% -59.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $456.6M $0.00
YoY Change
Debt Paid & Issued, Net $15.63M $7.812M
YoY Change 100.01%
Cash From Financing Activities $444.9M -$10.37M
YoY Change -4391.88% -345.09%
NET CHANGE
Cash From Operating Activities $30.92M $15.03M
Cash From Investing Activities -$67.80M -$25.29M
Cash From Financing Activities $444.9M -$10.37M
Net Change In Cash $408.0M -$20.63M
YoY Change -2077.27% -35.85%
FREE CASH FLOW
Cash From Operating Activities $30.92M $15.03M
Capital Expenditures $2.490M $7.511M
Free Cash Flow $28.43M $7.515M
YoY Change 278.28% -68.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001428336
CY2021Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2021Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2021Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q2 dei Amendment Flag
AmendmentFlag
false
CY2021Q2 dei Document Type
DocumentType
10-Q
CY2021Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q2 dei Document Period End Date
DocumentPeriodEndDate
2021-04-30
CY2021Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q2 dei Entity File Number
EntityFileNumber
001-36568
CY2021Q2 dei Entity Registrant Name
EntityRegistrantName
HEALTHEQUITY, INC.
CY2021Q2 dei Trading Symbol
TradingSymbol
HQY
CY2021Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2383166
CY2021Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
15 West Scenic Pointe Drive
CY2021Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2021Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Draper,
CY2021Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2021Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84020
CY2021Q2 dei City Area Code
CityAreaCode
801
CY2021Q2 dei Local Phone Number
LocalPhoneNumber
727-1000
CY2021Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2021Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2021Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021Q2 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
83389315 shares
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
736773000 USD
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
328803000 USD
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4648000 USD
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4239000 USD
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
74468000 USD
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
72767000 USD
CY2021Q2 us-gaap Other Assets Current
OtherAssetsCurrent
53870000 USD
CY2021Q1 us-gaap Other Assets Current
OtherAssetsCurrent
58607000 USD
CY2021Q2 us-gaap Assets Current
AssetsCurrent
865111000 USD
CY2021Q1 us-gaap Assets Current
AssetsCurrent
460177000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27479000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29106000 USD
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
86139000 USD
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
89508000 USD
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
780794000 USD
CY2021Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
767003000 USD
CY2021Q2 us-gaap Goodwill
Goodwill
1363568000 USD
CY2021Q1 us-gaap Goodwill
Goodwill
1327193000 USD
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
38778000 USD
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
37420000 USD
CY2021Q2 us-gaap Assets
Assets
3161869000 USD
CY2021Q1 us-gaap Assets
Assets
2710407000 USD
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
9636000 USD
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1614000 USD
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33045000 USD
CY2021Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
50670000 USD
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
73446000 USD
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75880000 USD
CY2021Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
62500000 USD
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
62500000 USD
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13677000 USD
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
14037000 USD
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
192304000 USD
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
204701000 USD
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
909820000 USD
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
924217000 USD
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71916000 USD
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
74224000 USD
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14811000 USD
CY2021Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8808000 USD
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
124748000 USD
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
119729000 USD
CY2021Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1121295000 USD
CY2021Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1126978000 USD
CY2021Q2 us-gaap Liabilities
Liabilities
1313599000 USD
CY2021Q1 us-gaap Liabilities
Liabilities
1331679000 USD
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
83377000 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83377000 shares
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
77168000 shares
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
77168000 shares
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2021Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1630529000 USD
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1158372000 USD
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
217733000 USD
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
220348000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1848270000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1378728000 USD
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3161869000 USD
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2710407000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184202000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
190011000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81086000 USD
CY2020Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81937000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
103116000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
108074000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14086000 USD
CY2020Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
11455000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35469000 USD
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31078000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20687000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18998000 USD
CY2021Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
19814000 USD
CY2020Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
18702000 USD
CY2021Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
8807000 USD
CY2020Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
12770000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
98863000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
93003000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4253000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
15071000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
6689000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
12263000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3630000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-764000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10319000 USD
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-13027000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6066000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2044000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3451000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
218000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2615000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2615000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1826000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1826000 USD
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81747000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70980000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81747000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72292000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1378728000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
1030295000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1848270000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1040650000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2615000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1826000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31768000 USD
CY2020Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27507000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12799000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
7396000 USD
CY2021Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1228000 USD
CY2020Q2 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1201000 USD
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-893000 USD
CY2020Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-972000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3243000 USD
CY2020Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3786000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
475000 USD
CY2020Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1074000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2249000 USD
CY2020Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
8360000 USD
CY2021Q2 hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-3369000 USD
CY2020Q2 hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-3104000 USD
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-17748000 USD
CY2020Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-22924000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-381000 USD
CY2020Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1362000 USD
CY2021Q2 hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-2308000 USD
CY2020Q2 hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-3045000 USD
CY2021Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-1104000 USD
CY2020Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
1127000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30918000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
15026000 USD
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
49533000 USD
CY2020Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q2 us-gaap Payments For Software
PaymentsForSoftware
15469000 USD
CY2020Q2 us-gaap Payments For Software
PaymentsForSoftware
11775000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2490000 USD
CY2020Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7511000 USD
CY2021Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
309000 USD
CY2020Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
6008000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67801000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25294000 USD
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
456642000 USD
CY2020Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15625000 USD
CY2020Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
7812000 USD
CY2021Q2 hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
353000 USD
CY2020Q2 hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
3776000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4189000 USD
CY2020Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1223000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
444853000 USD
CY2020Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-10365000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
407970000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20633000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328803000 USD
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191726000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
736773000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
171093000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
4988000 USD
CY2020Q2 us-gaap Interest Paid Net
InterestPaidNet
10749000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-4852000 USD
CY2020Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
733000 USD
CY2021Q2 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
3982000 USD
CY2020Q2 us-gaap Noncash Or Part Noncash Acquisition Intangible Assets Acquired1
NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1
1537000 USD
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
765000 USD
CY2020Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
968000 USD
CY2021Q2 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
8147000 USD
CY2020Q2 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2021Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
5000 USD
CY2020Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
0 USD
CY2021Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2615000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
1826000 USD
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81747000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70980000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81747000 shares
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70980000 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1312000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81747000 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
72292000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.03
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.03
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000 shares
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60315000 USD
CY2021Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60093000 USD
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
32836000 USD
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
30987000 USD
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27479000 USD
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
29106000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
3900000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
3900000 USD
CY2021Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4400000 USD
CY2021Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
4100000 USD
CY2021Q2 hqy Contract With Customer Recognition Term Interchange Arrangement
ContractWithCustomerRecognitionTermInterchangeArrangement
P10Y
CY2021Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
600000 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4313000 USD
CY2020Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4308000 USD
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
450000 USD
CY2020Q2 us-gaap Sublease Income
SubleaseIncome
450000 USD
CY2021Q2 us-gaap Lease Cost
LeaseCost
3863000 USD
CY2020Q2 us-gaap Lease Cost
LeaseCost
3858000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3635000 USD
CY2020Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3297000 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2020Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
17480000 USD
CY2021Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
408000 USD
CY2020Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
600000 USD
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5939000 USD
CY2020Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
94000 USD
CY2021Q2 hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
1901000 USD
CY2020Q2 hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
-1270000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3630000 USD
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-764000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1004367000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
962752000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
223573000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
195749000 USD
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
780794000 USD
CY2021Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
767003000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27900000 USD
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
23600000 USD
CY2021Q2 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
36400000 USD
CY2021Q2 hqy Lessee Operating Lease Lease Not Yet Commenced Undiscounted Amount
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedAmount
63100000 USD
CY2021Q2 hqy Lessee Operating Lease Lease Not Yet Commenced Undiscounted Term
LesseeOperatingLeaseLeaseNotYetCommencedUndiscountedTerm
P11Y
CY2021Q1 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
30000000.0 USD
CY2021Q2 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
30000000.0 USD
CY2018Q3 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2018Q2 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2021Q2 hqy Number Of Executives
NumberOfExecutives
2 executive
CY2021Q2 hqy Number Of Executives
NumberOfExecutives
2 executive
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3500000 USD
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.571
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.107
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.332
CY2020Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.168
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10500000 USD
CY2021Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
10200000 USD
CY2021Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
9700000 USD
CY2021Q2 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.0186
CY2021Q2 us-gaap Line Of Credit Facility Interest Rate At Period End
LineOfCreditFacilityInterestRateAtPeriodEnd
0.0239
CY2021Q2 hqy Debt Instrument Covenant Description Acquisition Threshold For Maximum Total Net Leverage Ratio
DebtInstrumentCovenantDescriptionAcquisitionThresholdForMaximumTotalNetLeverageRatio
100000000.0 USD
CY2021Q2 hqy Debt Instrument Covenant Description Interest Coverage Ratio
DebtInstrumentCovenantDescriptionInterestCoverageRatio
3.00
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13141000 USD
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7396000 USD
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1674000 shares
CY2021Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
1.25
CY2021Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.46
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
87164000 USD
CY2021Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
103000 shares
CY2021Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
14.00
CY2021Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
44.53
CY2021Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
26.46
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1571000 shares
CY2021Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
1.25
CY2021Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
31.79
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M12D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
69562000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1571000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
31.79
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
69562000 USD
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1463000 shares
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
29.08
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y6M
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
68694000 USD

Files In Submission

Name View Source Status
0001428336-21-000025-index-headers.html Edgar Link pending
0001428336-21-000025-index.html Edgar Link pending
0001428336-21-000025.txt Edgar Link pending
0001428336-21-000025-xbrl.zip Edgar Link pending
exhibit311-ceo302xfy22q1.htm Edgar Link pending
exhibit312-cfo302xfy22q1.htm Edgar Link pending
exhibit321-ceo906xfy22q1.htm Edgar Link pending
exhibit322-cfo906xfy22q1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hqy-20210430.htm Edgar Link pending
hqy-20210430.xsd Edgar Link pending
hqy-20210430_cal.xml Edgar Link unprocessable
hqy-20210430_def.xml Edgar Link unprocessable
hqy-20210430_htm.xml Edgar Link completed
hqy-20210430_lab.xml Edgar Link unprocessable
hqy-20210430_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending